Roche (ROG) Given a CHF 275 Price Target by Bank of America Analysts
Roche (VTX:ROG) has been assigned a CHF 275 price objective by investment analysts at Bank of America in a report released on Wednesday. The brokerage currently has a “buy” rating on the healthcare company’s stock. Bank of America’s price target indicates a potential upside of 11.25% from the company’s current price.
A number of other equities analysts have also recently issued reports on the company. J P Morgan Chase & Co reissued a “buy” rating and issued a target price on shares of Roche in a report on Thursday, November 2nd. Goldman Sachs Group set a CHF 325 target price on Roche and gave the stock a “buy” rating in a report on Monday, September 11th. Credit Suisse Group set a CHF 300 target price on Roche and gave the stock a “buy” rating in a report on Monday, September 11th. Berenberg Bank set a CHF 260 target price on Roche and gave the stock a “neutral” rating in a report on Monday, November 20th. Finally, set a CHF 203 price target on Roche and gave the stock a “sell” rating in a research report on Friday, October 20th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and eight have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of CHF 261.32.
Shares of Roche (VTX:ROG) traded up CHF 2.10 during trading hours on Wednesday, hitting CHF 247.20. 1,700,000 shares of the company were exchanged, compared to its average volume of 1,720,000. Roche has a 12-month low of CHF 219.10 and a 12-month high of CHF 273.
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.